NCT03086369 2022-06-28A Study of Nab-Paclitaxel and Gemcitabine With or Without Olaratumab (LY3012207) in Participants With Metastatic Pancreatic CancerEli Lilly and CompanyPhase 1/2 Completed184 enrolled 22 charts